Skip to main content
. 2014 Sep 3;4:6277. doi: 10.1038/srep06277

Figure 4. ROC curve analysis of the 2 novel miRNAs and SCC in diagnosing cervical cancer patients (N = 112) from healthy controls (N = 85).

Figure 4

(A) SCC (AUC = 0.690, 95% CI:0.605–0.776). (B) m1 represents PmiR-1 (AUC = 0.921, 95% CI:0.883–0.959); m2 represents PmiR-2 (AUC = 0.827, 95% CI: 0.767–0.887).